Pelvic Organ Prolapse Clinical Trial
— meshOfficial title:
Anatomical and Functional Outcomes of Perigee and Apogee Mesh in Total Pelvic Floor Reconstruction Versus Gynecare Prolift
Verified date | February 2017 |
Source | Nanjing Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The investigators designed a prospective study in this article to evaluate the efficacy, the life quality and the complications of two different meshes of type I (one is Perigee/Apogee, the other is named Gynecare prolift) versus traditional surgery, and also studied the influence of some surgical procedures on the prognosis.
Status | Completed |
Enrollment | 258 |
Est. completion date | January 30, 2014 |
Est. primary completion date | January 30, 2014 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 50 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Patients with stage III ~ IV degree of anterior and posterior vaginal wall prolapse and uterine prolapse (total pelvic floor prolapse) by the Pelvic Organ Prolapse Quantification System (POP-Q) were included Exclusion Criteria: - Simple anterior or posterior wall prolapse, simple uterine prolapse, combined with stress urinary incontinence, overactive bladder (OAB), pelvic floor repair surgery history and recurrent patients - Local or systemic conditions that would preclude surgery or affect healing such as restricted leg motion (inability to conform to the lithotomy position) - Vaginal bleeding;coagulation disorders - Infection,or uncontrolled hypertension and diabetes mellitus - Pelvic cancer and radiation to the pelvic area in the previous 6 months. - Also women of reproductive age, and planning of pregnancy were also excluded for mesh usage. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Nanjing Medical University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pelvic Organ Prolapse Quantification | the prolapse of stage II and above is defined as recurrence in POP-Q stage. | at 12 months after surgery | |
Primary | sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire | PISQ-12 | at 12 months after surgery | |
Primary | pelvic floor distress inventory short form | PFDI-20 | at 12 months after surgery | |
Primary | mesh exposure | mesh was seen in the vagina by gynecological examination | at 12 months after surgery | |
Primary | sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire | PISQ-12 | at 24 months after surgery | |
Primary | Pelvic Organ Prolapse Quantification | the prolapse of stage II and above is defined as recurrence in POP-Q stage. | at 24 months after surgery | |
Primary | pelvic floor distress inventory short form | PFDI-20 | at 24 months after surgery | |
Primary | mesh exposure | mesh was seen in the vagina by gynecological examination | at 24 months after surgery | |
Primary | sexual quality of life through the pelvic organ prolapse / urinary incontinence sexual questionnaire | PISQ-12 | baseline | |
Primary | pelvic floor distress inventory short form | PFDI-20 | baseline | |
Secondary | stress urinary incontinence | leakage of urine with exertion or with sneezing or coughing | at 1 months after surgery | |
Secondary | stress urinary incontinence | leakage of urine with exertion or with sneezing or coughing | 3 months after surgery | |
Secondary | Volume of bleeding | during the operation | ||
Secondary | Elevated blood pressure | during the operation | ||
Secondary | Day of postoperative indwelling catheter | 1 months after surgery | ||
Secondary | Number of constipation | 1 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05422209 -
The Influence of Simultaneous Posterior Colporrhaphy and Perineoplasty on the Efficiency and Safety of Mesh-augmented Sacrospinal Fixation (Apical Sling) in Advanced POP Repair.
|
N/A | |
Active, not recruiting |
NCT05420831 -
Comparison of Vaginal and Laparoscopic Apical Fixation Techniques for Pelvic Organ Prolapse Treatment
|
N/A | |
Completed |
NCT05493735 -
Lidocaine for Pessary Check Pain Reduction
|
Phase 3 | |
Completed |
NCT06126328 -
Materna Prep Study Phase II
|
Phase 2 | |
Recruiting |
NCT05542836 -
EVeRLAST 2-Year Follow-Up
|
||
Recruiting |
NCT05918367 -
Multicenter Ventral Mesh Rectopexy Registry Collaborative
|
||
Recruiting |
NCT04172272 -
The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures
|
N/A | |
Recruiting |
NCT04807920 -
BOTOX® at the Time of Prolapse Surgery for OAB
|
Phase 4 | |
Completed |
NCT06268782 -
The Effectiveness of an Online Exercise Program on Well-being of Postpartum Women
|
N/A | |
Recruiting |
NCT03146195 -
The 3D Reconstruction Research of Pelvic Organ Prolapse Disease
|
N/A | |
Recruiting |
NCT02919852 -
Laparoscopic Retrovesical Colpopectinopexia
|
N/A | |
Completed |
NCT02925585 -
Vaginal Tactile Imaging for Pelvic Floor Prolapse
|
||
Not yet recruiting |
NCT02536001 -
Prospective Randomized Study to Compare Results of Pelvic Organ Prolapse Repair With One Versus Two Vaginal Meshes
|
N/A | |
Recruiting |
NCT02113969 -
Conservative Management of Symptomatic Pelvic Organ Prolapse Using Vaginal Pessaries: Generation of a Standardized Management Protocol
|
N/A | |
Completed |
NCT02383199 -
Polypropylene Mesh in Prolapse Surgery
|
N/A | |
Terminated |
NCT01673360 -
Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices
|
N/A | |
Completed |
NCT01842464 -
Sacro-Spinous Ligaments Anterior Apical Anchoring
|
N/A | |
Withdrawn |
NCT01530191 -
Factors Affecting Perioperative Outcomes
|
N/A | |
Completed |
NCT01320631 -
Male Sexual Experience and Its Impact on Quality of Life Before and After Their Sexual Partners Undergo Polypropylene Mesh Augmented Pelvic Floor Reconstruction
|
N/A | |
Completed |
NCT00581412 -
Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates
|
N/A |